Showing 18,621 - 18,640 results of 226,405 for search '(( a ((((a decrease) OR (linear decrease))) OR (larger decrease)) ) OR ( a large decrease ))', query time: 1.20s Refine Results
  1. 18621
  2. 18622
  3. 18623

    Dissolution proxies for holes 1207A, 1208A, and 1209A. by Adriane R. Lam (9127871)

    Published 2020
    “…<p>Dissolution intervals were approximated by calculating a ratio of susceptible to resistant species [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0234351#pone.0234351.ref077" target="_blank">77</a>]. …”
  4. 18624
  5. 18625
  6. 18626

    Dataset on the Chemical Modification of Ascorbic Acid (AA) to L-ascorbyl-6-palmitate (AP): A Novel Approach For Improved Antioxidant Therapy in Traumatic Brain Injury (TBI) by Umar Faruk Saidu (16446285)

    Published 2024
    “…<p dir="ltr">The data support the findings of the research entitled, Chemical Modification of Ascorbic Acid (AA) to L-ascorbyl-6-palmitate (AP): A Novel Approach For Improved Antioxidant Therapy in Traumatic Brain Injury.…”
  7. 18627

    CA-induced MTT and crystal violet reduction and protection by Ber in N2a cells. by Xiaofeng Liu (35910)

    Published 2014
    “…<p>CA decreased cell viability in a dose-dependent manner as determined by MTT and crystal violet assay (<b>A</b>) and Ber increased cell viability in a dose-dependent manner until to 25 μg/ml in 2.5 nmol/L CA-treated cells (<b>B</b>). 25 μg/ml Ber showed significant protection of the cells from CA-induced lesions. …”
  8. 18628

    Effect of dilution and DMSO concentration on the interaction of NF-κB/DNA complex with the inhibitors. by Rodrigo Villagomez (685829)

    Published 2015
    “…<p><b>a)</b> Effect of 1) active compound <b>1</b>; 2) inactive compound <b>4</b>; B1) control complex NF-κB:DNA target and B2) free DNA target, at four different dilutions of the system: I) Initial conditions; II) Inhibitor at ¾, NF-κB at ¾ and DNA target to ½ of initial concentration; III) Diluting inhibitor to ½, NF-κB to ½ and DNA target to ¼ of initial concentration and IV) Diluting inhibitor at ½, NF-κB at ½ and DNA target at ¼ of initial concentration. …”
  9. 18629

    The Assembly of EDC4 and Dcp1a into Processing Bodies Is Critical for the Translational Regulation of IL-6 by Eri Seto (243456)

    Published 2015
    “…Interestingly, knocking down EDC4 or Dcp1a, which are components of P-bodies, severely reduced the production of IL-6, but not TNF-α in M1-THPs without decreasing the amount of IL-6 mRNA. …”
  10. 18630
  11. 18631

    MCPIP1 ribonuclease can bind and cleave <i>AURKA</i> mRNA in <i>MYCN</i>-amplified neuroblastoma cells by Iwona Nowak (9283821)

    Published 2021
    “…We showed that the levels of several transcripts involved in cell cycle progression decreased in BE(2)-C and KELLY cells overexpressing MCPIP1 in a ribonucleolytic activity-dependent manner. …”
  12. 18632
  13. 18633
  14. 18634
  15. 18635
  16. 18636
  17. 18637
  18. 18638

    Cytochrome bd-II oxidase CyxA promotes the pathogenicity of <i>Klebsiella pneumoniae</i> by resisting oxidative stress by Xiao Xiao (99147)

    Published 2025
    “…Additionally, the expression levels of <i>cyxA</i> at 37°C and 41°C were significantly higher compared to 30°C, and the Δ<i>cyxA</i> strain exhibited significantly lower viable counts, elevated intracellular reactive oxygen species (ROS) levels, and decreased total antioxidant capacity (T-AOC) relative to WT at 37°C and 41°C. …”
  19. 18639

    Improving the Oxidative Stability of a High Redox Potential Fungal Peroxidase by Rational Design by Verónica Sáez-Jiménez (731925)

    Published 2015
    “…Substitution of these residues, located near the heme cofactor and the catalytic tryptophan, rendered a variant with a 7.8-fold decreased oxidative inactivation rate. …”
  20. 18640

    Epigenome- and Transcriptome-wide Changes in Muscle Stem Cells from Low Birth Weight Men by Christa Broholm (155817)

    Published 2020
    “…<p><b>Background</b>: Being born with low birth weight (LBW) is a risk factor for muscle insulin resistance and type 2 diabetes (T2D), which may be mediated by epigenetic mechanisms programmed by the intrauterine environment. …”